Ontology highlight
ABSTRACT:
SUBMITTER: Moskowitz AJ
PROVIDER: S-EPMC5691245 | biostudies-literature | 2017 Nov
REPOSITORIES: biostudies-literature
Moskowitz Alison J AJ Schöder Heiko H Gavane Somali S Thoren Katie L KL Fleisher Martin M Yahalom Joachim J McCall Susan J SJ Cadzin Briana R BR Fox Stephanie Y SY Gerecitano John J Grewal Ravinder R Hamlin Paul A PA Horwitz Steven M SM Kumar Anita A Matasar Matthew M Ni Andy A Noy Ariela A Palomba M Lia ML Perales Miguel-Angel MA Portlock Carol S CS Sauter Craig C Straus David D Younes Anas A Zelenetz Andrew D AD Moskowitz Craig H CH
Blood 20170905 20
Identification of prognostic factors for patients with relapsed/refractory Hodgkin lymphoma (HL) is essential for optimizing therapy with risk-adapted approaches. In our phase 2 study of positron emission tomography (PET)-adapted salvage therapy with brentuximab vedotin (BV) and augmented ifosfamide, carboplatin, and etoposide (augICE), we assessed clinical factors, quantitative PET assessments, and cytokine and chemokine values. Transplant-eligible patients with relapsed/refractory HL received ...[more]